Given the multiple pro-cancer roles of NOTCH2 in the initiation, progression, maintenance of CSC properties, and chemoresistance of pancreatic cancer, NOTCH2 represented an attractive potential therapeutic target. The gene discussed is NOTCH2; the disease is pancreatic neoplasm.